Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Current assets:    
Cash and cash equivalents $ 14,240 $ 16,871
Short- term investments 8,888
Receivables 546 1,189
Current-other asset 195 49
Deferred financing costs 121 134
Prepaid expenses 977 835
Total current assets 16,079 27,966
Investments 20
Other asset 473 417
Equipment 1,910 2,107
Right of Use Asset 147
Intangible assets 4,244 6,386
Total assets 22,853 36,896
Current liabilities:    
Trade and other payables 7,319 12,307
Unsecured convertible debentures 1,361
Lease liability 76
Total current liabilities 7,395 13,668
Derivative warrant liabilities 2,393 12,183
Lease Liability 71
Total liabilities 9,859 25,851
Shareholders’ Equity:    
Common shares 137,424 110,857
Additional paid-in capital 9,797 8,150
Accumulated other comprehensive loss (7,887) (7,135)
Accumulated deficit (126,340) (100,827)
Total Shareholder’s equity 12,994 11,045
Commitments and contingencies
Total liabilities and shareholders’ equity $ 22,853 $ 36,896